These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 31993992)
1. Generic levothyroxine initiation and substitution among Medicare and Medicaid populations: a new user cohort study. Huo N; Chen L; Ullah Mishuk A; Li C; Hansen RA; Harris I; Kiptanui Z; Wang Z; Dutcher SK; Qian J Endocrine; 2020 May; 68(2):336-348. PubMed ID: 31993992 [TBL] [Abstract][Full Text] [Related]
2. Generic escitalopram initiation and substitution among Medicare beneficiaries: A new user cohort study. Li C; Chen L; Huo N; Mishuk AU; Hansen RA; Harris I; Kiptanui Z; Wang Z; Qian J PLoS One; 2020; 15(4):e0232226. PubMed ID: 32353006 [TBL] [Abstract][Full Text] [Related]
3. Patient factors associated with oral generic olanzapine initiation and substitution among Medicaid beneficiaries: a new user cohort study. Mishuk AU; Chen L; Li C; Huo N; Hansen RA; Harris I; Kiptanui Z; Qian J Curr Med Res Opin; 2021 Apr; 37(4):655-664. PubMed ID: 33507825 [TBL] [Abstract][Full Text] [Related]
4. Oral generic tacrolimus initiation and substitution in the Medicaid population: a new user cohort study. Chen L; Li C; Huo N; Mishuk AU; Hansen RA; Harris I; Kiptanui Z; Qian J Curr Med Res Opin; 2020 Sep; 36(9):1533-1540. PubMed ID: 32644886 [TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels. Brito JP; Ross JS; Sangaralingham L; Dutcher SK; Graham DJ; Wang Z; Wu Y; Yao X; Smallridge RC; Bernet V; Shah ND; Lipska KJ JAMA Netw Open; 2020 Sep; 3(9):e2017645. PubMed ID: 32997127 [TBL] [Abstract][Full Text] [Related]
6. Generic and Brand-Name Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016. Ross JS; Rohde S; Sangaralingham L; Brito JP; Choi L; Dutcher SK; Graham DJ; Jenkins MR; Lipska KJ; Mendoza M; Qiang Y; Wang Z; Wu Y; Yao X; Shah ND J Clin Endocrinol Metab; 2019 Jun; 104(6):2305-2314. PubMed ID: 30690529 [TBL] [Abstract][Full Text] [Related]
7. Real world evidence in effectiveness, safety, and cost savings of generic levothyroxine: a systematic review. Qian J; Tanni KA Endocrine; 2021 Nov; 74(2):228-234. PubMed ID: 34322821 [TBL] [Abstract][Full Text] [Related]
8. Patterns and predictors of generic narrow therapeutic index drug use among older adults. Gagne JJ; Polinski JM; Kesselheim AS; Choudhry NK; Hutchins D; Matlin OS; Tong A; Shrank WH J Am Geriatr Soc; 2013 Sep; 61(9):1586-91. PubMed ID: 24001285 [TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study. Gagne JJ; Choudhry NK; Kesselheim AS; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH Ann Intern Med; 2014 Sep; 161(6):400-7. PubMed ID: 25222387 [TBL] [Abstract][Full Text] [Related]
10. Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries. Sumarsono A; Sumarsono N; Das SR; Vaduganathan M; Agrawal D; Pandey A JAMA Netw Open; 2020 Feb; 3(2):e200181. PubMed ID: 32108893 [TBL] [Abstract][Full Text] [Related]
11. Rates of, and factors associated with, switching among generic levothyroxine preparations in commercially insured American adults. Brito JP; Deng Y; Ross JS; Choi NH; Graham DJ; Qiang Y; Rantou E; Wang Z; Zhao L; Shah ND; Lipska KJ Endocrine; 2022 May; 76(2):349-358. PubMed ID: 35107758 [TBL] [Abstract][Full Text] [Related]
12. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents. Sacks CA; Lee CC; Kesselheim AS; Avorn J JAMA; 2018 Aug; 320(7):650-656. PubMed ID: 30140875 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Incident Cardiovascular Event Rates Between Generic and Brand l-Thyroxine for the Treatment of Hypothyroidism. Smallridge RC; Sangaralingham LR; Mwangi R; Kusumoto F; Van Houten H; Bernet V Mayo Clin Proc; 2019 Jul; 94(7):1190-1198. PubMed ID: 31036352 [TBL] [Abstract][Full Text] [Related]
15. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs. Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684 [TBL] [Abstract][Full Text] [Related]
16. Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Goedken AM; Urmie JM; Farris KB; Doucette WR Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109 [TBL] [Abstract][Full Text] [Related]
17. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit. Fischer MA; Avorn J Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087 [TBL] [Abstract][Full Text] [Related]
18. Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients. Kwong WJ; Kamat S; Fang C Ann Pharmacother; 2012 Dec; 46(12):1609-16. PubMed ID: 23150608 [TBL] [Abstract][Full Text] [Related]
19. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry. O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864 [TBL] [Abstract][Full Text] [Related]
20. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting. Rathe JØ Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]